The Action Mechanism of Cyclooxygenase‐2 Inhibitor for Treatment of Experimental Allergic Neuritis

Muscle and Nerve - United States
doi 10.1002/(sici)1097-4598(199912)22:12<1704::aid-mus13>3.3.co;2-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley-Blackwell

Related search

Novel Strategy for Cystitis Glandularis: Oral Treatment With Cyclooxygenase-2 Inhibitor

International Journal of Urology
Urology
2016English

Relation of Clinical, Serological, Morphological, and Electrophysiological Findings in Galactocerebroside-Induced Experimental Allergic Neuritis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1986English

Can a Cyclooxygenase Inhibitor Be an Option for Treatment of Ovarian Hyperstimulation Syndrome?

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Scaffold of the Cyclooxygenase-2 (COX-2) Inhibitor Carprofen Provides Alzheimer G-Secretase Modulators

English

Successful Treatment of an Unresectable Inflammatory Myofibroblastic Tumor of the Frontal Bone Using a Cyclooxygenase-2 Inhibitor and Methotrexate

Internal Medicine
Internal MedicineMedicine
2013English

Immunosuppressive Effect of FK506 on Experimental Allergic Neuritis in Lewis Rats: Change of T Cell Subsets.

Internal Medicine
Internal MedicineMedicine
1992English

The Protective Effects of Ursodeoxycholic Acid and the Selective Cyclooxygenase-2 Inhibitor Celecoxib on Liver Damage in an Experimental Cholestasis Model

Experimental Biomedical Research
2019English

Safety of a Cyclooxygenase-2 Inhibitor in Patients With Aspirin-Sensitive Asthma

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2002English

On the Mechanism of Action of 2, 4-Dichlorophenoxyacetic Acid

Australian Journal of Biological Sciences
1949English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy